NASDAQ$BTMD
biote Corp · Q4 2025 earnings
Q4 2025 earnings · · After market close · Investor relations
Briefing
Biote reported Q4 2025 revenue of $46.4M with net income of $2.6M and operating income of $6.8M.
For the quarter ended December 31, 2025, Biote generated revenue of $46.4 million with net income of $2.6 million. Operating income increased 146.8% to $6.8 million on clinic network growth in hormone optimization.
- Q4 revenue $46.4M.
- Net income $2.6M; operating income $6.8M.
- FY2025 net income $31.6M.
- Clinic partner network expansion.
- Operating leverage improving.
Headline financials
Revenue & EPS history
biote · Revenue · Quarterly
$46.4M
Forward guidance
Continued clinic additions and same-clinic growth expected.
Tailwinds
- Strong operating income growth.
Headwinds
- Competitive wellness market.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q4 2025
-2.4%
Avg return
Earnings day
-4.0%
Avg return
5 days after
-3.0%
Avg return
30 days after
55%
11 / 20 earnings
Positive
+16.9%
Q3 2024
Best reaction
-25.1%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.9% | -9.6% | +4.6% | |
| Q4 2025 | -10.5% | -20.9% | -7.6% | |
| Q3 2025 | -2.4% | -11.1% | -13.0% | |
| Q1 2025 | +11.3% | +17.1% | +14.7% | |
| Q4 2024 | -25.1% | -0.7% | -11.0% | |
| Q3 2024 | +16.9% | -6.3% | +13.7% | |
| Q2 2024 | -21.2% | -17.8% | -10.6% | |
| Q1 2024 | +0.2% | +1.0% | +11.1% | |
| Q4 2023 | +11.9% | +27.0% | +10.1% | |
| Q3 2023 | -20.2% | -18.4% | -0.9% | |
| Q2 2023 | -14.4% | -22.0% | -23.7% | |
| Q1 2023 | -17.2% | -14.3% | -20.6% | |
| Q4 2022 | +16.6% | +34.9% | +33.3% | |
| Q3 2022 | +2.3% | +2.5% | +7.2% | |
| Q2 2022 | +1.1% | -4.6% | -7.4% | |
| Q1 2022 | +0.6% | -36.9% | -64.3% | |
| Q4 2021 | +0.0% | +0.0% | +0.6% | |
| Q3 2021 | -0.1% | +0.1% | +1.0% | |
| Q2 2021 | +0.0% | -0.5% | -0.2% | |
| Q1 2021 | +0.6% | +0.6% | +3.0% | |
| Q4 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro